These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1473746)

  • 1. Characterization and clinical evaluation of tumor-associated antigen CA54/61 identified by monoclonal antibodies MA54 and MA61 in epithelial ovarian cancer.
    Kobayashi H; Ohi H; Sugimura M; Shinohara H; Terao T
    Gynecol Oncol; 1992 Dec; 47(3):328-36. PubMed ID: 1473746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of monoclonal antibodies reactive with meconium- and amniotic fluid-derived mucin.
    Kobayashi H; Ohi H; Terao T
    J Clin Lab Anal; 1994; 8(1):27-34. PubMed ID: 8164108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated mucin-type glycoprotein (CA54/61) defined by two monoclonal antibodies (MA54 and MA61) in ovarian cancers.
    Nozawa S; Yajima M; Kojima K; Iizuka R; Mochizuki H; Sugawara T; Iwamori M; Nagai Y
    Cancer Res; 1989 Jan; 49(2):493-8. PubMed ID: 2910468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies MA54 and MA61 as potential reagents in the prognosis of patients with ovarian cancer.
    Kobayashi H; Ohi H; Sugimura M; Shinohara H; Terao T
    Gynecol Oncol; 1993 Apr; 49(1):80-5. PubMed ID: 8482565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new method for diagnosis of amniotic fluid embolism by means of monoclonal antibody TKH-2 that recognizes mucin-type glycoprotein, a component in meconium].
    Ohi H; Kobayashi H; Sugimura M; Terao T
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jul; 44(7):813-9. PubMed ID: 1354239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of a tumor marker (CA54/61) and its individual epitopes recognized by monoclonal antibodies, MA54 and MA61, in human tumor patients.
    Mochizuki H; Nagoya K; Yamauchi T; Takao Y; Masuko H; Sato H; Sasaki H; Itoh K; Tsukazaki K; Udagawa Y
    J Clin Lab Anal; 1992; 6(4):225-31. PubMed ID: 1383482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The usefulness and limitation of sugar antigen in ovarian cancers--with special reference to a new tumor marker, CA54/61].
    Nozawa S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1147-51. PubMed ID: 2499263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The evaluation of CA54/61 in the diagnosis of ovarian cancer--with special reference to the cooperative results of 5 institutes].
    Nozawa S; Yajima M; Udagawa Y; Kiguchi K; Iizuka R; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1823-9. PubMed ID: 2687409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heterogeneity of the CA125 antigen that coexpresses sialyl Tn and CA19-9 antigens].
    Kobayashi H; Ohi H; Shinohara H; Terao T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):980-6. PubMed ID: 8371024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
    Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
    Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunoenzymometric assay for a CA125-like antigen, CA602.
    Mochizuki H; Sato I; Nagoya K; Furusako S; Yamauchi T; Masuko H; Sato H; Morishita H; Yajima M; Sasaki H
    J Clin Lab Anal; 1992; 6(2):84-90. PubMed ID: 1383480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-colorectal carcinoma monoclonal antibodies reactive with human milk fat globular membranes.
    Teh JG; Xing PX; McKenzie IF
    Immunol Cell Biol; 1990 Jun; 68 ( Pt 3)():207-16. PubMed ID: 1699885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA54/61 as a marker for epithelial ovarian cancer.
    Nozawa S; Aoki D; Yajima M; Tsukazaki K; Kobayashi T; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y
    Cancer Res; 1992 Mar; 52(5):1205-9. PubMed ID: 1737381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma--comparison with CA125.
    McGuckin MA; Layton GT; Bailey MJ; Hurst T; Khoo SK; Ward BG
    Gynecol Oncol; 1990 May; 37(2):165-71. PubMed ID: 1693126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of new cancer-associated antigen CA125 II in epithelial ovarian cancers: comparison with CA125.
    Kobayashi H; Tamura M; Satoh T; Terao T
    Clin Biochem; 1993 Jun; 26(3):213-9. PubMed ID: 8330391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II).
    Nozawa S; Yajima M; Sasaki H; Tsukazaki K; Aoki D; Sakayori M; Udagawa Y; Kobayashi T; Sato I; Furusako S
    Jpn J Cancer Res; 1991 Jul; 82(7):854-61. PubMed ID: 1715339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
    Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
    J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    J Clin Oncol; 1992 Jan; 10(1):95-101. PubMed ID: 1727929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.
    Kobayashi H; Ohi H; Fujii T; Terao T
    Br J Cancer; 1993 Feb; 67(2):237-43. PubMed ID: 7679280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of cancer-associated carbohydrate antigens in the diagnosis and therapy of human cancers].
    Kannagi R; Shigeta K; Hirashima K; Takada A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1157-66. PubMed ID: 2658813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.